ArticleSignal transduction and targeted therapy2026

Receptor-defined targeting of a genomically unique melanoma-enriched noncanonical antigen.

Thomas Morgan Hulen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.